CytoReason

Activities: Digital

Trending Articles

  1. OINDPs: Nosey about recent developments? OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
  2. Transforming healthcare with patient centricity In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
  3. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  4. Compact process thermostat for efficient temperature control in the laboratory The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
  5. AviadoBio expands presence at Canary Wharf The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

Manufacturing

Poolbeg Pharma reveals "significant breakthrough" in influenza AI program

Alongside CytoReason, the analysis has led to the discovery of multiple novel drug targets for the treatment of influenza
Research & Development

AI drug development specialist CytoReason enters the Japanese market

CytoReason and Summit Pharmaceuticals International have announced that CytoReason has entered the Japanese market with its technology being utilised by one of Japan's top pharmaceutical companies
Research & Development

Cytoreason and Pfizer to use machine learning model of the immune system for drug discovery

CytoReason, a leader in machine learning for drug discovery and development, has entered into a collaboration agreement with Pfizer that will leverage CytoReason’s cell-centred models of the immune system
Digital

Using AI to personalise drug treatments

CytoReason, an immune-focused artificial intelligence technology company generates insights to reveal complex patterns in a variety of biological data
Subscribe now